R

Replay

44 employees

Replay is a genome writing company reprogramming biology by writing and delivering big DNA.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Hypo-immunogenic cell therapy
Gene editing
Therapeutics
Enzyme writing
Genome writing
Gene therapy
Transcriptional regulation

Date founded

2021

Funding rounds raised

Total raised

$55M

from 5 investors over 5 rounds

R

Replay raised $55M on July 25, 2022

Investors: SALT Ventures Indonesia, OMX Ventures, KKR & Co. Inc. and ARTIS Ventures

R

Replay raised undisclosed on August 1, 2020

Investors: ARTIS Ventures

FAQ